Paola Teegarden

发表

KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma

S. Munich, M. Ciesielski, R. Fenstermaker, 2018, Journal of Neuro-Oncology.

Dual Inhibition of the Epidermal Growth Factor Receptor with Cetuximab, an IgG1 Monoclonal Antibody, and Gefitinib, A Tyrosine Kinase Inhibitor, in Patients with Refractory Non-small Cell Lung Cancer (NSCLC): A Phase I Study

S. Ramalingam, Martin R. Weber, C. Belani, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.